The antibiotic arms race: current and emerging therapy for Klebsiella pneumoniae carbapenemase (KPC) - producing bacteria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The antibiotic arms race: current and emerging therapy for Klebsiella pneumoniae carbapenemase (KPC) - producing bacteria

Published:2018-11-05 Issue:18 Volume:19 Page:2019-2031
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Plazak Michael E.¹,Tamma Pranita D.²,Heil Emily L.³

Affiliation:

1. Department of Pharmacy, University of Maryland Medical Center , Baltimore, MD, USA

2. Department of Pediatrics, Johns Hopkins University School of Medicine , Baltimore, MD, USA

3. Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy , Baltimore, MD, USA

Funder

manuscript was

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1538354

Reference100 articles.

1. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

2. Carbapenem resistance in Enterobacteriaceae: here is the storm!

3. Carbapenemases: the Versatile β-Lactamases

4. The global epidemiology of carbapenemase-producing Enterobacteriaceae

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Klebsiella pneumoniae carbapenemase (KPC) β-Lactamase Has Evolved in Response to Ceftazidime Avibactam;Antibiotics;2023-12-31

2. Dynamic evolution of ceftazidime–avibactam resistance due to interchanges between blaKPC-2 and blaKPC-145 during treatment of Klebsiella pneumoniae infection;Frontiers in Cellular and Infection Microbiology;2023-08-21

3. Allelic diversity uncovers protein domains contributing to the emergence of antimicrobial resistance;PLOS Genetics;2023-03-27

4. Allelic diversity uncovers protein domains contributing to the emergence of antimicrobial resistance;2022-10-24

5. Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives;Revista Española de Quimioterapia;2022-10-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3